Treace Medical Concepts Reports First Quarter 2024 Financial Results
May 07, 2024 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Weyco Reports First Quarter Sales and Earnings
May 07, 2024 16:05 ET
|
Weyco Group
MILWAUKEE, May 07, 2024 (GLOBE NEWSWIRE) -- Weyco Group, Inc. (NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced financial results for the quarter ended March 31, 2024. First...
Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
May 07, 2024 16:05 ET
|
Y-mAbs Therapeutics, Inc.
Reported U.S. DANYELZA® net product revenues of $18.6 million for the first quarter of 2024, representing a YoY increase of 11% Reported Worldwide DANYELZA net product revenues of $19.4 million for...
Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability
May 07, 2024 16:05 ET
|
Clover Health Investments, Corp.
First Quarter 2024 Insurance Revenue growth of 8% year-over-year First Quarter 2024 GAAP Net Loss from Continuing Operations of $23.2 million versus First Quarter 2023 loss of $79.7 million First...
Lesaka to acquire leading payment platform Adumo welcoming new shareholders Apis and ARC
May 07, 2024 16:05 ET
|
Lesaka Technologies
JOHANNESBURG, South Africa, May 07, 2024 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) (“Lesaka”) has signed a definitive agreement to acquire Adumo RF (Pty) Ltd (“Adumo”)...
A-Mark Precious Metals Reports Fiscal Third Quarter 2024 Results
May 07, 2024 16:05 ET
|
A-Mark Precious Metals
Q3 FY 2024 Diluted Earnings Per Share of $0.21 Repurchased 204,396 Common Shares for $5 Million Expanded into Asia with the Previously Announced Acquisition of LPM Group Limited Company Reaffirms...
Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
May 07, 2024 16:05 ET
|
Viracta Therapeutics, Inc.
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers...
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
May 07, 2024 16:05 ET
|
OPKO Health, Inc.
MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2024. First quarter business...
ODDITY Tech Reports Record First Quarter Results, Raises Outlook
May 07, 2024 16:05 ET
|
Oddity Tech Ltd.
Record first quarter net revenue of $212 million, up 28% year-over-yearRecord first quarter net income of $33 million, up 68% year-over-year, and record first quarter adjusted net income of $38...
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
May 07, 2024 16:05 ET
|
MaxCyte, Inc
ROCKVILLE, Md., May 07, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...